Placental Therapeutic Targets and Nanodelivery Systems.

Abstract

Pregnancy complications affect millions of women each year. Some of these diseases have high morbidity and mortality such as preeclampsia. At present, there is no safe and effective treatment for pregnancy complications, so it is still a difficult clinical problem. As many pregnancy complications are closely related to placental dysplasia, placenta-specific therapy, as an important method, is expected to be a safe, effective, and specific therapeutic strategy. This review explains in detail the placenta physiological structure, characteristics, and action mechanism of some biomolecules and signaling pathways that play roles in normal development and disorders of the development of the placenta, and how to use these biomolecules as therapeutic targets when the placenta disorder causes disease, combining the latest progress in the field of nanodelivery systems, so as to lay a foundation for the development of placenta-specific therapy of pregnancy complications.

• Authors: Yang Liu, Xingli Gao, Songwei Gao, Yu Song, Yongran Guo, Jing Cao
• Journal: Molecular pharmaceutics (Mol Pharm) Vol. 19 Issue 11 Pg. 3730-3748 (11 07 2022) ISSN: 1543-8392 [Electronic] United States
• PMID: 36228175 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)

Chemical References

• Nanoparticle Drug Delivery System

Topics

• Pregnancy
• Female
• Humans
• Nanoparticle Drug Delivery System
• Placenta (metabolism)
• Pre-Eclampsia (drug therapy, etiology, metabolism)
• Pregnancy Complications (drug therapy)